Controversies in neuro-oncology: Focal proton versus photon radiation therapy for adult brain tumors.
brain tumors
chordomas
gliomas
meningiomas
proton beam
radiosurgery
radiotherapy
Journal
Neuro-oncology practice
ISSN: 2054-2577
Titre abrégé: Neurooncol Pract
Pays: England
ID NLM: 101640528
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
pmc-release:
29
04
2025
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
epublish
Résumé
Radiation therapy (RT) plays a fundamental role in the treatment of malignant and benign brain tumors. Current state-of-the-art photon- and proton-based RT combines more conformal dose distribution of target volumes and accurate dose delivery while limiting the adverse radiation effects. PubMed was systematically searched from from 2000 to October 2023 to identify studies reporting outcomes related to treatment of central nervous system (CNS)/skull base tumors with PT in adults. Several studies have demonstrated that proton therapy (PT) provides a reduced dose to healthy brain parenchyma compared with photon-based (xRT) radiation techniques. However, whether dosimetric advantages translate into superior clinical outcomes for different adult brain tumors remains an open question. This review aims at critically reviewing the recent studies on PT in adult patients with brain tumors, including glioma, meningiomas, and chordomas, to explore its potential benefits compared with xRT.
Identifiants
pubmed: 39006517
doi: 10.1093/nop/npae040
pii: npae040
pmc: PMC11241386
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
369-382Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Déclaration de conflit d'intérêts
HS receives honoraria from UpToDate (section editor, writer), MedLink Neurology (writer). GM has received honoraria for speaker activity and travel support from Brainlab and Accuray.